Introduction
Aortic aneurysm is a common condition, often asymptomatic, until catastrophic aneurysm rupture, but the mortality increases when rupture occurs before surgery. The pathogenesis of aortic aneurysm appears to be characterized by widespread destruction of elastic lamellae in the media (1-3), medial neovascularization (4), a decrease in vascular smooth muscle cells (5) , and a chronic inflammatory response in the of years with a substantial number of aneurysmal aortae eventually rupturing (13) (14) (15) . The pathophysiology of the aneurysmal aorta includes aortic atherosclerosis, chronic inflammation within the outer aortic wall, and an imbalance between the production and degradation of structural extracellular matrix proteins (16) . Ang II has been suggested to be related to aortic aneurysm, based on the findings that Ang II infusions into mice promote aortic aneurysm (17) , and saltloaded hypertensive mice are characterized by higher Ang II levels occurring in hemorrhage prior to the development of aneurysm (18) . We have reported that Ang II is generated from Ang I by two distinct types of Ang II-forming enzymes, angiotensin converting enzyme (ACE) and chymase in human cardiovascular tissues (19, 20) , and that ACE and chymase are associated with the development of atherosclerosis (8, 20, 21) . Ihara et al. (22) reported that the ratio of chymase-dependent Ang II-forming activity to total Ang IIforming activity was significantly higher in the aneurysmal aortae (94.8%) than in the normal aortae (85.6%). Furthermore, they also reported significant increases in chymase-dependent Ang II-forming activity in the aneurysmal aortae. However, this study was limited only to patients who had not been treated with ACE inhibitors.
The aims of the present study were: 1) to measure the ACE and chymase-like enzyme activities in the human aneurysmal aorta; 2) to study the effect of ACE inhibitors on ACE and chymase-like enzyme activities in the aneurysmal aorta; and 3) to analyze the activity of Ang II-forming enzymes in the intima, media and adventitia in the aneurysmal aorta.
Materials and Methods

Tissue Procurement
Aortic aneurysmal specimens (N 16, all from male patients) were obtained at the time of operative aneurysm repair from patients ranging in age from 50 to 78 years. Control aortic specimens were obtained from 16 patients (all men, 47 to 81 years) who underwent coronary artery bypass surgery. Eight of the patients with aortic aneurysm and 8 of the control patients had been administered ACE inhibitors orally before surgery. All vessels were rinsed with phosphate-buffered saline at 4ºC. In the aneurysmal aortic tissues, the intima, media and adventitia were further separated with scissors. All subjects gave their informed written consent after a full explanation of the purpose of this study. Approval of the protocol, which complied with the principles of the Helsinki Declaration, was obtained from the designated review board of the institution involved.
Tissue Preparation and Extraction for Enzyme Assay
The aneurysmal and control aortic specimens were minced and homogenized in 10 volumes (w/v) of 20 mmol/l Naphosphate buffer, pH 7.4. The homogenate was centrifuged at 20,000 g for 30 min. The supernatant was discarded, and the pellet was re-suspended and homogenized in 5 volumes (w/v) of 10 mmol/l Na-phosphate buffer, pH 7.4, containing 2 mol/l KCl and 0.1% Nonidet P-40. The homogenate was stored overnight at 4ºC, and centrifuged at 20,000 g for 30 min. The supernatant was used for measurement of the ACE and chymase-like enzyme activities.
Measurement of ACE and Chymase-like Enzyme Activities
ACE activity was measured using a synthetic substrate, hippuryl-His-Leu, specifically designed for ACE (Peptide Inst. Inc., Osaka, Japan). The tissue extract was incubated for 30 min at 37ºC with 5 mmol/l hippuryl-His-Leu in 10 mmol/l phosphate buffer, pH 8.3, containing 600 mmol/l NaCl (23). The reaction was terminated by addition of 3% metaphosphoric acid, and then the mixture was centrifuged at 20,000 g for 5 min at 4ºC. The supernatant was applied to a reversed-phase column (4 mm i.d. 250 mm, IRICA Instrument, Kyoto, Japan) that had been equilibrated with 10 mmol/l KH2PO4 and CH3OH (1:1, pH 3.0), and eluted with the same solution at a rate of 0.3 ml/min. Hippuric acid was detected by ultraviolet absorbance at 228 nm. One unit of ACE activity was defined as the amount of enzyme that cleaved 1 µmol hippuric acid/min.
Chymase-like enzyme activity was measured by incubating tissue extracts for 30 min at 37ºC with 4 mmol/l Ang I in 150 mmol/l borax-borate buffer, pH 8.5, containing 8 mmol/l dipyridyl, 770 µmol/l diisopropyl fluorophosphate and 5 mmol/l ethylenediaminetetraacetic acid, as described previously (23) . The reaction was terminated by addition of 15% trichloroacetic acid, and then the mixture was centrifuged at 20,000 g for 5 min at 4ºC. For the fluorometric quantitation of His-Leu formed from an Ang I substrate, 10% o-phthaldialdehyde (dissolved in methanol) was added to the supernatant in the alkaline state, and the mixture was incubated for 10 min at room temperature. The reaction was terminated by addition of 6 mol/l HCl and the fluorescence was measured at 340 nm excitation and 455 nm emission. One unit of chymase activity was defined as the amount of enzyme that cleaved 1 µmol His-Leu/min. A blank was also included, with an addition of 500 µmol/l chymostatin.
Protein concentration was assayed with BCA Protein Assay Reagents (Pierce, Rockford, USA) using bovine serum albumin as a standard.
Statistical Analysis
To compare the ACE and chymase-like enzyme activities in the aneurysmal and control aortae, a statistical analysis was conducted using Student's t-test. To compare the ACE and chymase-like enzyme activities in each layer of the aneurysmal aortae, a statistical analysis was performed using a para- (Fig. 2) . The chymase-like enzyme activity in the aneurysmal and control aortae in the patients treated with ACE inhibitors were 26.3 0.59 mU/mg protein and 1.65 0.38 mU/mg protein, respectively. The activity in the aneurysmal aortae was thus about 16 times higher than that in the control aortae. In the patients not treated with ACE inhibitors, the chymase-like enzyme activity in the aneurysmal aortae was about 8 times higher than that in the control aortae (Fig. 2) .
The ACE activities in both the aneurysmal and control aortae of the ACE inhibitors-treated patients tended to be lower than those in the patients not treated with ACE inhibitors (Fig. 3) . If the ACE activity in the patients not treated with ACE inhibitors is regarded as 100%, then the ACE activities in the aneurysmal aortae and control aortae of the patients treated with ACE inhibitors are 71.3% and 87.5%, respectively (Fig. 3) . The chymase-like activity in the control aortae of the patients treated with ACE inhibitors tended to be lower than that in the patients not treated with ACE inhibitors (Fig. 3) . On the other hand, in the aneurysmal aortae, the chymase-like enzyme activity in the patients treated with ACE inhibitors was about 1.5 times higher than that in the patients not treated with ACE inhibitors (Fig. 3) .
Upon investigation of each layer in the aneurysmal aortae, metric test with Fisher's Protected Least Significant Difference. Values of p 0.05 were considered statistically significant. Data are expressed as the mean SEM. Table 1 shows the age and mean blood pressure of the 16 aneurysmal and 16 control patients enrolled in the study. The age and mean blood pressure were not significantly different between patients who were administered ACE inhibitors and those who were not. However, among the patients treated with ACE inhibitors, the mean blood pressure in those with aortic aneurysm was significantly higher than that in the controls.
Results
The ACE activities in all of the aneurysmal and control aortae were 0.93 0.09 mU/mg protein and 0.15 0.01 mU/mg protein, respectively, and this difference was significant (Fig. 1) . The chymase-like enzyme activities in all of the aneurysmal and control aortae were 21.5 3.45 mU/mg protein and 1.62 0.24 mU/mg protein, respectively, and this difference was also significant (Fig. 1) .
Among the patients treated with ACE inhibitors, the aneurysmal aortae showed significantly higher ACE activity than the control aortae (aneurysmal aortae, 0.77 0.11 mU/mg protein; control aortae, 0.14 0.02 mU/mg protein) (Fig. 2) . Among those not treated with ACE inhibitors, the aneurysmal aortae also showed significantly higher ACE activity than the control aortae (aneurysmal aortae, 1.08 0.14 mU/mg protein; control aortae, 0.16 0.02 mU/mg protein) 
Fig. 2. ACE and chymase-like activities in the aneurysmal and the control aortae in the presence (ACE inhibitor) and absence (Non-ACE inhibitor) of the ACE inhibitors.
no significant differences in ACE activity were found among the layers in the ACE inhibitors-treated patients (intima, 0.68 0.10 mU/mg protein; media, 0.65 0.11 mU/mg protein; adventitia, 0.99 0.15 mU/mg protein) (Fig. 4) . In the patients not treated with ACE inhibitors, significant differences in the ACE activities of the various layers were also not observed (intima, 1.12 0.31 mU/mg protein; media, 0.99 0.19 mU/mg protein; adventitia, 1.23 0.25 mU/mg protein) (Fig. 4) . On the other hand, the chymase-like enzyme activity in the adventitia was significantly higher than in the other layers in the ACE inhibitors-treated patients (intima, 2.27 0.59 mU/mg protein; media, 4.44 2.66 mU/mg protein; adventitia, 60.0 7.16 mU/mg protein) (Fig. 4) . In the patients not treated with ACE inhibitors, the chymaselike enzyme activity in the adventitia was significantly higher than that in the intima or in the media, but there was no significant difference between the intima and the media (intima, 2.09 0.45 mU/mg protein; media, 11.4 5.95 mU/mg protein; adventitia, 52.5 15.6 mU/mg protein) (Fig. 4) .
Discussion
In the present study, we investigated the relationship between aortic aneurysm and the Ang II-forming enzymes, ACE and chymase-like enzyme. The ACE and chymase-like enzyme activities in all of the aneurysmal aortae were about 6 and 13 times higher than those in all of the control aortae, respectively. Previously, Ihara et al. (22) reported that the ACE-dependent and chymase-dependent Ang II-forming activities in the aneurysmal aortae in patients who had not been treated with ACE inhibitors were about 3 and 5 times higher, respectively, than those in the normal aortae. In the present study, the activities of both ACE and chymase-like enzyme in the aneurysmal aortae were significantly higher than those in the control aortae not only in the absence of ACE inhibitors but also in the presence of ACE inhibitors. In the aneurysmal aortae, the ACE activity in the patients treated with ACE inhibitors tended to be lower than that in the patients not treated with ACE inhibitors, while the chymaselike enzyme activity in the patients treated with ACE inhibitors was about 1.5 times higher than that in the patients not treated with ACE inhibitors. Using immunohistochemical analysis, Ihara et al. (22) reported that chymase-positive mast cells were increased in the adventitia of aneurysmal aortae. We also observed that chymase-like enzyme activity in the adventitia was significantly higher than that in the intimal or medial layers. These significant increases of chymase-like enzyme activities in the vascular tissues may indicate that this enzyme plays an important role in the progression of aortic aneurysm. In the present study, the chymase-like enzyme activity in the aneurysmal aortae in the presence of ACE inhibitors tended to be higher than that in the absence of ACE inhibitors, although the ACE activity in the aneurysmal aortae tended to be reduced by treatment with ACE inhibitors. This result suggests that ACE inhibitors could not suppress the chymase-like enzyme activities in the aneurysmal aortae. This conclusion is supported by previous findings in a rat model, in which neointima formation in vessels injured by a catheter was prevented by an ACE inhibitor (24) . However, clinical trials in which an ACE inhibitor was used in an attempt to prevent restenosis after percutaneous transluminal coronary angioplasty (PTCA) were unsuccessful (25) . Such species differences in the effects of ACE inhibitors on neointimal formation may result from species differences in the Ang II-forming pathways. Rat vascular tissues contain ACE as the only Ang II-forming enzyme, while human vascular tissues contain chymase in addition to ACE as Ang II-forming enzymes (26) . In a recent clinical study, an Ang II receptor antagonist was shown to suppress the restenosis after stent and PTCA (27) . Therefore, it is thought that ACE inhibitors cannot suppress chymase-dependent Ang II formation in human vascular tissues. In our present study, in the presence of ACE inhibitors, the chymase-like enzyme activity was significantly increased in the aneurysmal aortae, suggesting that Ang II receptor antagonists may be more useful for suppressing aneurysmal formation than ACE inhibitors.
In the present study, the chymase-like enzyme activity in the adventitia was strongly increased in the aneurysmal aortae. Chymase processes and activates pro-matrix metalloproteinase to matrix metalloproteinase (MMP), which is a strong tissue-degradative protease (28) . Generally, however, MMP is balanced by the tissue inhibitor of metalloproteinase (TIMP), and tissue degradation is dependent on an imbalance between MMP and TIMP (29) . Chymase cleaves TIMP to inactive fragments, and it also cleaves complexes of MMP and TIMP, which have no MMP activity, to form active MMP (29) . MMP activation by chymase may contribute to tissue degradation. In aneurysmal diseases, many reports have demonstrated a correlation between an increase of MMP in the adventitia and aneurysmal formation (30) (31) (32) (33) . In fact, MMP inhibitors have been shown to suppress aneurysmal formation in animal models (34, 35) . The increase of chymase in the adventitia of the aneurysmal aorta may be related to the activation of MMP from pro-MMP in addition to Ang II from Ang I.
In this study, we demonstrated that chymase-like enzyme activities in aneurysmal aortae were significantly higher than those in control aortae, in spite of treatment with ACE inhibitors. Therefore, increases in local Ang II formation by chymase-like enzymes may play important roles in the pathogenesis of aneurysmal formation.
